Most Quality teams are staffed for their “steady state.” The trouble comes from everything else that inevitably happens: an inspection date on the calendar, a backlog that quietly grew faster than anyone could close it, a remediation window after an FDA visit, a QMS in need of help without a specialist, a key role sitting empty while new candidates are sent through the modern hiring gauntlet.
Those situations need someone on contract to work within the team, often full-time, for a defined period. Project-based consulting doesn’t quite fit because the work isn’t a discrete deliverable. It’s daily or otherwise regular execution alongside the people who are already there.
That’s the model we call staff augmentation. A full-time consultant, or FTC. The consultant works as part of the client’s Quality organization, within their systems, reporting to their leaders, for as long as needed, under a flexible contract that can be extended if needed.
We’re seeing more Quality needs naturally lend themselves to this model, and it can be used to address a variety of needs. Here are four recent engagements that show what that looks like in practice in case it’s a strategic solution for you — now or later.
1. Clearing an investigation backlog while building the bench
We’ve been working with a pharma manufacturing site that had built up a significant backlog of open and overdue deviation investigations. At the same time, it was starting to implement an investigator qualification program to strengthen its own people.
We dropped in two full-time consultants who have embedded themselves in many similar organizations before for very similar work, primarily on-site, for roughly three to six months. The job was to write, manage, and drive manufacturing investigations through to closure, covering equipment failures, human error, and procedural noncompliance, with root cause analysis that would hold up.
For the second half of the scope, our experts were asked to coach and train site personnel on root cause investigation as the qualification program came online. And the client specified prior cGMP inspection experience, so the people closing investigations would recognize the weaknesses an investigator looks for. This “get the work done, then coach on doing that work” model is a motif that extends to all kinds of Quality work through a staff augmentation model.
It fits here so well because a backlog is volume work that has to happen inside the site’s own systems and with its own people. Pairing execution with coaching was designed to pay down the backlog while building the site’s capability to keep up with investigations on its own.
It’s an excellent use case for FTCs.
2. Leading a medical device site through FDA inspection preparation
A medical device manufacturer we’ve worked with on several projects had an FDA inspection scheduled at a site outside the United States, with a team that was new to FDA inspections. A mock audit was already on the calendar.
They needed an experienced QA leader to work 30 to 40 hours a week for at least three months, traveling to the site regularly. The role would attend the mock audit, then lead the roughly four weeks of remediation, documentation, and storyboarding that followed. During the inspection itself, the consultant would serve as the primary contact, coordinating responses and representing the company.
An interesting part of this engagement was that the company preferred industry-side inspection experience over prior FDA investigator experience for this role to avoid conflicting perspectives. The job mixed hands-on work with coaching, and company leadership wanted a steady physical presence during the critical weeks to build confidence with site leadership.
The FTC model works well here, too, because this kind of inspection preparation has a fixed end date and many judgment calls along the way. The team needed one accountable person fully allocated to handle planning and actual execution, not a series of advisory calls.
3. Putting validation engineers on the floor after FDA observations
We commonly augment internal teams in response to regulatory events, too. In one recent example, a high-volume manufacturing site running continuous production had received FDA inspectional observations via a 483. They hadn’t affected production, and the team wanted to keep it that way by getting ahead of the process fixes.
We deployed a small team of on-site validation quality engineers with specific process validation experience in high-speed, high-volume manufacturing, starting right after a planned plant shutdown, on first shift, for at least six months.
Company leaders also raised a related need for on-site quality systems support covering CAPA and management controls.
Local talent for these roles was scarce near the site, which made the search harder.
And because we were already an approved vendor in the company’s system, having worked together before, the SOW and purchase order could be issued quickly once candidates were identified. (We maintain convenient MSAs for teams that want to save administrative time when they need fast support.)
Bringing in contracted specialists worked here since validation work at a running plant is extremely hands-on and has to happen where the equipment is. The company needed experienced engineers on the floor for a sustained stretch, timed to the plant’s own schedule.
4. Bridging to a permanent hire during a busy inspection season
FTCs are useful if you’re a clinical-stage company, too. We recently worked with a clinical-stage sponsor whose Clinical QA Director was heading into a period with regulatory inspections on the calendar in more than one region, alongside pharmacovigilance oversight, CRO oversight, and ongoing internal audit follow-up. The company planned to hire a permanent QA manager but needed coverage right away. (FTCs are great when you don’t have time to wait for an FTE to get hired and onboarded — or if the work for that role won’t be permanent and ongoing.)
We embedded a hands-on QA manager-level professional to act as the director's right hand:
Fielding daily questions from clinical teams.
Leading responses to internal audit findings and CAPAs in the company's quality management system
Representing QA in meetings
Signing off on documents so the director could concentrate on inspection preparation.
The consultant would work closely with the director until the permanent hire was onboarded.
This is the clearest version of a bridge. The permanent role was coming, but the inspection calendar wasn't going to wait for recruiting to finish. A full-time consultant covered the gap while recruiting ran its course.
What these engagements have in common
A few throughlines here:
A clock, not a headcount gap. Every one of these needs had a date or a volume attached: an inspection, a backlog, a remediation window, a hire. That’s usually the signal that full-time consulting fits better than adding permanent headcount or buying a discrete project. But certainly not the only signal.
Very specific experience requirements. The requests didn’t ask for “a quality consultant.” They asked for prior cGMP inspection experience for investigation work, industry-side inspection hosting over investigator experience, process validation in high-speed manufacturing, and GCP and pharmacovigilance depth for clinical QA. The more precisely a team can describe the experience it needs, the faster the right person can be found.
Knowledge transfer written into the scope. Two of the four put coaching in the scope directly: training site personnel on root cause investigation and coaching a team new to FDA inspections. If the capability is meant to outlast the engagement, it belongs in the scope from day one.
On-site when the work demands it. The backlog and validation engagements were built around physical presence, and the inspection engagement required regular travel to the site. Remote works for a lot of Quality work. It doesn’t work for everything, and the requests reflected that.
Paperwork is part of the timeline. In the validation engagement, the existing vendor approval let the contracting move quickly. Teams that expect to need outside support at some point can save weeks by getting a firm through vendor onboarding before the need turns urgent.
Initial terms often grow. Across our Quality FTC work over the past year, extensions are common. Several engagements have been extended once or more after the first term, and one has run in successive extensions since before mid-2025. Scoping a realistic initial term, with a clear path to extend, tends to serve both sides better than an optimistic one.
If this sounds familiar…
If your Quality team is looking at an inspection date, a backlog, a remediation effort, or an open role it can’t fill fast enough, this is the kind of support we provide. Tell us what the next one to six months look like, and we’ll tell you whether a full-time consultant is the right answer. Learn more and get in touch.
Watch our great conversation with Mark Shapiro on clinical outsourcing vs. insourcing for more on this topic:
Who is The FDA Group?
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on Quality Assurance, Regulatory Affairs, and Clinical Operations.
With thousands of resources worldwide, hundreds of whom are former FDA, we meet your precise resourcing needs through a fast, convenient talent selection process supported by a Total Quality Guarantee. Learn more and schedule a call with us to see if we’re a fit to help you access specialized professionals and execute your projects on time and on budget.